Hadas Reuveni
Chief Tech/Sci/R&D Officer at PURPLE BIOTECH LTD
Hadas Reuveni active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PURPLE BIOTECH LTD | Chief Tech/Sci/R&D Officer | 01/01/2017 | - |
Tyrnovo Ltd.
 Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Chief Executive Officer | - | - |
| Founder | - | - |
Career history of Hadas Reuveni
Former positions of Hadas Reuveni
| Companies | Position | Start | End |
|---|---|---|---|
NovoTyr Therapeutics Ltd.
 NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Chief Executive Officer | 01/01/2005 | 01/01/2012 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 01/01/2001 | 01/01/2004 |
AngioB Ltd.
 AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Director/Board Member | 01/07/2006 | - |
| Chief Tech/Sci/R&D Officer | 01/07/2006 | - | |
| Founder | 01/06/2010 | - |
Training of Hadas Reuveni
| The Hebrew University of Jerusalem | Doctorate Degree |
Statistics
International
| Israel | 6 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 5 |
| Retail Trade | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PURPLE BIOTECH LTD | Health Technology |
| Private companies | 4 |
|---|---|
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Health Technology |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Retail Trade |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Hadas Reuveni
- Experience
